73
Views
5
CrossRef citations to date
0
Altmetric
Review Article

An update on the medical therapy of advanced metastatic renal cell carcinoma

, , , , , , & show all
Pages 501-506 | Received 07 Jun 2007, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Axel S Merseburger, Annika Simon, Sandra Waalkes & Markus A Kuczyk. (2009) Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer. Expert Review of Anticancer Therapy 9:10, pages 1429-1434.
Read now

Articles from other publishers (4)

Vijaya L. Damaraju, Michelle Kuzma, Delores Mowles, Carol E. Cass & Michael B. Sawyer. (2015) Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?. Molecular Cancer Therapeutics 14:1, pages 236-245.
Crossref
Stephan Kruck, Axel S. Merseburger, Joerg Hennenlotter, Marcus Scharpf, Christian Eyrich, Bastian Amend, Karl-Dietrich Sievert, Arnulf Stenzl & Jens Bedke. (2012) High cytoplasmic expression of p27Kip1 is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. BJU International 109:10, pages 1565-1570.
Crossref
Stephan Kruck, Joerg Hennenlotter, Ulrich Vogel, David Schilling, Georgios Gakis, Joachim Hevler, Ursula Kuehs, Arnulf Stenzl & Christian Schwentner. (2012) Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications. BJU International 109:4, pages 634-638.
Crossref
Gennady BratslavskyZiya Kirkali. (2010) The Changing Face of Renal-Cell Carcinoma. Journal of Endourology 24:5, pages 753-757.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.